Impact of graft type on outcomes following liver transplantation for primary sclerosing cholangitis

Israni AK, Zaun D, Hadley N, et al. OPTN/SRTR 2018 annual data report: deceased organ donation. Am J Transplant. 2020;20 Suppl 1:509–41. https://doi.org/10.1111/ajt.15678

Article  PubMed  Google Scholar 

Chapman R, Fevery J, Kalloo A, et al. AASLD Practice Guideline: Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–78.

Article  CAS  PubMed  Google Scholar 

Gordon FD, Goldberg DS, Goodrich NP, et al. Recurrent primary sclerosing cholangitis in the adult-to-adult living donor liver transplantation cohort study: comparison of risk factors between living and deceased donor recipients. Liver Transplant. 2016;22(9):1214–22. https://doi.org/10.1002/lt.24496

Article  Google Scholar 

Dyson JK, Webb G, Hirschfield GM, et al. Unmet clinical need in autoimmune liver diseases. J Hepatol. 2015;62(1):208–18. https://doi.org/10.1016/j.jhep.2014.09.010

Article  PubMed  Google Scholar 

Goldberg D, Bittermann T, Makar G. Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis. Am J Transplant. 2012;12(6):1603–9. https://doi.org/10.1111/j.1600-6143.2011.03969.x

Article  PubMed  Google Scholar 

Goldberg DS, French B, Thomasson A, Reddy KR, Halpern SD. Current trends in living donor liver transplantation for primary sclerosing cholangitis. Transplantation. 2011;91(10):1148–52. https://doi.org/10.1097/TP.0b013e31821694b3

Article  PubMed  Google Scholar 

Egawa H, Ueda Y, Ichida T, et al. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry. Am J Transplant. 2011;11(3):518–27. https://doi.org/10.1111/j.1600-6143.2010.03402.x

Article  PubMed  Google Scholar 

Goldberg DS, French B, Abt PL, Olthoff K, Shaked A. Superior survival using living donors and donor-recipient matching using a novel living donor risk index. Hepatology. 2014;60(5):1717–26. https://doi.org/10.1002/hep.27307

Article  PubMed  Google Scholar 

Orman ES, Barritt AS, Wheeler SB, Hayashi PH. Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. Liver Transplant. 2013;19(1):59–68. https://doi.org/10.1002/lt.23547

Article  Google Scholar 

Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg. 2011;253(4):817–25. https://doi.org/10.1097/SLA.0b013e3182104784

Article  PubMed  Google Scholar 

Hildebrand T, Pannicke N, Dechene A, et al. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis. Liver Transplant. 2016;22(1):42–52. https://doi.org/10.1002/lt.24350

Article  Google Scholar 

Sundaram V, Choi G, Jeon CY, et al. Donation after cardiac death liver transplantation in primary sclerosing cholangitis. Transplantation. 2015;99(5):973–8. https://doi.org/10.1097/TP.0000000000000447

Article  CAS  PubMed  Google Scholar 

Trivedi PJ, Scalera I, Slaney E, et al. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis. J Hepatol. 2017;67(5):957–65. https://doi.org/10.1016/j.jhep.2017.06.027

Article  PubMed  Google Scholar 

Croome KP, Taner CB. The changing landscapes in DCD liver transplantation. Curr Transplant Rep. 2020;7:194–204. https://doi.org/10.1007/s40472-020-00283-1

Article  PubMed  Google Scholar 

Leppke S, Leighton T, Zaun D, et al. Scientific registry of transplant recipients: collecting, analyzing, and reporting data on transplantation in the United States. Transplant Rev. 2013;27(2):50–6. https://doi.org/10.1016/j.trre.2013.01.002

Article  Google Scholar 

Tamura S, Sugawara Y, Kaneko J, Matsui Y, Togashi J, Makuuchi M. Recurrence of primary sclerosing cholangitis after living donor liver transplantation. Liver Int. 2007;27(1):86–94. https://doi.org/10.1111/j.1478-3231.2006.01395.x

Article  PubMed  Google Scholar 

Haga H, Miyagawa-Hayashino A, Taira K, et al. Histological recurrence of autoimmune liver diseases after living-donor liver transplantation. Hepatol Res. 2007;37(s3):S463–9. https://doi.org/10.1111/j.1872-034X.2007.00245.x

Article  PubMed  Google Scholar 

Kashyap R, Safadjou S, Chen R, et al. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases-an analysis of the UNOS database. J Gastrointest Surg. 2010;14(9):1362–9. https://doi.org/10.1007/s11605-010-1256-1

Article  PubMed  Google Scholar 

Aravinthan AD, Doyle AC, Issachar A, et al. First-degree living-related donor liver transplantation in autoimmune liver diseases. Am J Transplant. 2016;16(12):3512–21. https://doi.org/10.1111/ajt.13828

Article  PubMed  Google Scholar 

Heinemann M, Liwinski T, Adam R, et al. Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: experience from the European liver transplant registry. Am J Transplant. 2022;22(2):626–33. https://doi.org/10.1111/ajt.16864

Article  PubMed  Google Scholar 

Blok JJ, Detry O, Putter H, et al. Longterm results of liver transplantation from donation after circulatory death. Liver Transplant. 2016;22(8):1107–14. https://doi.org/10.1002/lt.24449

Article  Google Scholar 

Mateo R, Cho Y, Singh G, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant. 2006;6(4):791–6. https://doi.org/10.1111/j.1600-6143.2006.01243.x

Article  CAS  PubMed  Google Scholar 

Dubbeld J, Hoekstra H, Farid W, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg. 2010;97(5):744–53. https://doi.org/10.1002/bjs.7043

Article  PubMed  Google Scholar 

Taylor R, Allen E, Richards JA, et al. Survival advantage for patients accepting the offer of a circulatory death liver transplant. J Hepatol. 2019;70(5):855–65. https://doi.org/10.1016/j.jhep.2018.12.033

Article  PubMed  Google Scholar 

Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2017 annual data report: liver. Am J Transplant. 2019;19 Suppl 2:184–283. https://doi.org/10.1111/AJT.15276

Article  PubMed  Google Scholar 

Alabraba E, Nightingale P, Gunson B, et al. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transplant. 2009;15(3):330–40. https://doi.org/10.1002/lt.21679

Article  Google Scholar 

Fleetwood VA, Janek K, Leverson G, et al. Predicting the safe use of deceased after circulatory death liver allografts in primary sclerosing cholangitis. Exp Clin Transplant. 2021;19(6):563–69. https://doi.org/10.6002/ect.2020.0387

Article  PubMed  Google Scholar 

Kubota T, Hata K, Sozu T, et al. Impact of donor age on recipient survival in adult-to-adult living-donor liver transplantation. Ann Surg. 2018;267(6):1126–33. https://doi.org/10.1097/SLA.0000000000002194

Article  PubMed  Google Scholar 

Berenguer M, Di Maira T, Baumann U, et al. Characteristics, trends and outcomes of liver transplantation for primary sclerosing cholangitis in female vs male patients: an analysis from the European liver transplant registry. Transplantation. 2021;105(10):2255–62. https://doi.org/10.1097/TP.0000000000003542

Article  CAS  Google Scholar 

Comments (0)

No login
gif